Repair of Osteochondral Defects With Adipose Stem Cells and a Dual Growth Factor-Releasing Scaffold in Rabbits

被引:54
作者
Im, Gun-Il [1 ]
Lee, Jin Ho [2 ]
机构
[1] Dongguk Univ, Ilsan Hosp, Dept Orthopaed, Goyang, South Korea
[2] Hannam Univ, Dept Adv Mat, Taejon, South Korea
关键词
cartilage; tissue engineering; stem cells; growth factor-immobilized scaffold; polycaprolactone; BONE MORPHOGENETIC PROTEIN-2; CHONDROGENIC DIFFERENTIATION; HEPARAN-SULFATE; TISSUE; CARTILAGE; THERAPY; MARROW;
D O I
10.1002/jbm.b.31552
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this work was to evaluate the in vivo effectiveness of a TGF-beta(2) and bone morphogenetic protein (BMP)-7-immobilized porous polycaprolactone (PCL)/F127 scaffold to enhance the healing of cartilage defect. An osteochondral defect was created on the patellar groove of the right distal femur of 12 rabbits and managed by one of the following methods: filling it with the scaffold only (Group 1); the scaffold seeded with adipose stem cells (ASCs) (Group II); a TGF-beta(2), and BMP-7-immobilized scaffold (Group III); and a TGF-beta(2) and BMP-7-immobilized scaffold seeded with ASCs (Group IV). Each group had three rabbits. Nine weeks after the implantation, the implanted scaffolds were filled with yellowish, dense tissue, and had distinct margins with adjacent normal cartilage. The histological findings showed infiltration of foreign-body giant cells and blood vessel, more prominently in Groups III and TV. The presence of growth factor significantly increased the ICRS Macroscopic Score (p = 0.045) while the presence of ASC did not. The ICRS Visual Histological Score was not significantly affected by the presence of either growth factors or ASCs, showing similar values in all groups. In conclusion, the use of TGF-beta(2) and BMP-7-immobilized PCL/F127 scaffolds improved gross appearances of the osteochondral defects while not actually leading to better histological results and induced a greater degree of foreign body reaction. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 552-560, 2010
引用
收藏
页码:552 / 560
页数:9
相关论文
共 33 条
[1]  
Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
[2]  
BEISER I H, 1990, Journal of Foot Surgery, V29, P595
[3]   Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes [J].
Breinan, HA ;
Martin, SD ;
Hsu, HP ;
Spector, M .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2000, 18 (05) :781-789
[4]  
Buckwalter JA, 1988, INSTR COURSE LECT, V47, P487
[5]   Tissue engineering and cell therapy of cartilage and bone [J].
Cancedda, R ;
Dozin, B ;
Giannoni, P ;
Quarto, R .
MATRIX BIOLOGY, 2003, 22 (01) :81-91
[6]   Principles of tissue engineered regeneration of skeletal tissues [J].
Caplan, AI ;
Goldberg, VM .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (367) :S12-S16
[7]  
CHILDERS JC, 1979, CLIN ORTHOP RELAT R, P114
[8]  
Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI 10.1089/tea.2007.0293
[9]   Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison [J].
Huang, JI ;
Kazmi, N ;
Durbhakula, MM ;
Hering, TM ;
Yoo, JU ;
Johnstone, B .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (06) :1383-1389
[10]   Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? [J].
Im, GI ;
Shin, YW ;
Lee, KB .
OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (10) :845-853